ARYA Sciences Acquisition Corp V (ARYE) Research

ARYA Sciences Acquisition Corp V currently has no substantial business activities. This company, established in 2021 and based in New York, New York, was formed with the specific aim of completing a business combination, such as a merger, acquisition of shares or assets, or a reorganization, with one or more entities operating within the healthcare or related sectors.

Market snapshot

Symbol
ARYE
Price
$10.36
Day change
-0.19%
Market cap
$198.8M
P/E ratio
11.78x
52-week range
9.7-10.5
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Alpha Healthcare Acquisition Corp. III (ALPA)
  • AxonPrime Infrastructure Acquisition Corporation (APMI)
  • BioPlus Acquisition Corp. (BIOS)
  • FACT II Acquisition Corp (FACT)
  • Galata Acquisition Corp. (GLTA)
  • Jaws Juggernaut Acquisition Corporation (JUGG)
  • Kadem Sustainable Impact Corporation (KSI)
  • Northern Genesis Acquisition Corp. III (NGC)

Recent insider activity

  • Stone Adam Leo — A-Award (499000 shares) on 2021-07-15
  • ARYA Sciences Holdings V — J-Other (499000 shares) on 2021-07-15
  • ALTMAN MICHAEL SETH — A-Award (499000 shares) on 2021-07-15
  • Patel Sanjiv — trade (30000 shares) on 2021-07-12
  • Yu Debra — trade (30000 shares) on 2021-07-12

Open ARYA Sciences Acquisition Corp V (ARYE) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.